The CD83 Molecule – An Important Immune Checkpoint

The CD83 molecule has been identified to be expressed on numerous activated immune cells, including B and T lymphocytes, monocytes, dendritic cells, microglia, and neutrophils. Both isoforms of CD83, the membrane-bound as well as its soluble form are topic of intensive research investigations. Several studies revealed that CD83 is not a typical co-stimulatory molecule, but rather plays a critical role in controlling and resolving immune responses. Moreover, CD83 is an essential factor during the differentiation of T and B lymphocytes, and the development and maintenance of tolerance. The identification of its interaction partners as well as signaling pathways have been an enigma for the last decades. Here, we report the latest data on the expression, structure, and the signaling partners of CD83. In addition, we review the regulatory functions of CD83, including its striking modulatory potential to maintain the balance between tolerance versus inflammation during homeostasis or pathologies. These immunomodulatory properties of CD83 emphasize its exceptional therapeutic potential, which has been documented in specific preclinical disease models.

[1]  A. Steinkasserer,et al.  Quercetin induces an immunoregulatory phenotype in maturing human dendritic cells. , 2020, Immunobiology.

[2]  A. Steinkasserer,et al.  Herpes Simplex Virus Type-2 Paralyzes the Function of Monocyte-Derived Dendritic Cells , 2020, Viruses.

[3]  X. Geng,et al.  Soluble CD83 alleviates experimental allergic rhinitis through modulating antigen-specific Th2 cell property , 2020, International journal of biological sciences.

[4]  T. Winkler,et al.  CD83 orchestrates immunity towards self and non-self in dendritic cells. , 2019, JCI insight.

[5]  M. Zygmunt,et al.  CD83 is locally regulated and differentially expressed in disturbed murine pregnancy. , 2019, Reproduction.

[6]  A. Steinkasserer,et al.  Endogenous Expression of the Human CD83 Attenuates EAE Symptoms in Humanized Transgenic Mice and Increases the Activity of Regulatory T Cells , 2019, Front. Immunol..

[7]  P. Silveira,et al.  CD83: Activation Marker for Antigen Presenting Cells and Its Therapeutic Potential , 2019, Front. Immunol..

[8]  M. Rauh,et al.  Soluble CD83 Triggers Resolution of Arthritis and Sustained Inflammation Control in IDO Dependent Manner , 2019, Front. Immunol..

[9]  J. Hauber,et al.  The acidic protein rich in leucines Anp32b is an immunomodulator of inflammation in mice , 2019, Scientific Reports.

[10]  Hongxia Wei,et al.  Abnormal Expression of Indoleamine 2, 3-Dioxygenase in Human Recurrent Miscarriage. , 2019, Reproductive sciences.

[11]  J. Myśliwska,et al.  Putative loss of CD83 immunosuppressive activity in long-standing complication-free juvenile diabetic patients during disease progression , 2019, Immunologic research.

[12]  G. Schett,et al.  Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis , 2018, Nature Reviews Rheumatology.

[13]  Alison S Care,et al.  Regulatory T cells in embryo implantation and the immune response to pregnancy , 2018, The Journal of clinical investigation.

[14]  Y. Kochi,et al.  Reduction of CD83 Expression on B Cells and the Genetic Basis for Rheumatoid Arthritis: Comment on the Article by Thalayasingam et al , 2018, Arthritis & rheumatology.

[15]  H. Bi,et al.  Soluble CD83 Alleviates Experimental Autoimmune Uveitis by Inhibiting Filamentous Actin-Dependent Calcium Release in Dendritic Cells , 2018, Front. Immunol..

[16]  H. Keyvani,et al.  The levels of soluble forms of CD21 and CD83 in multiple sclerosis , 2018, Journal of Neuroimmunology.

[17]  T. Winkler,et al.  CD83 expression is essential for Treg cell differentiation and stability. , 2018, JCI insight.

[18]  A. Barton,et al.  CD4+ and B lymphocyte expression quantitative traits at rheumatoid arthritis risk loci in untreated early arthritis: implications for causal gene identification , 2018 .

[19]  A. Barton,et al.  CD4+ and B Lymphocyte Expression Quantitative Traits at Rheumatoid Arthritis Risk Loci in Patients With Untreated Early Arthritis , 2018, Arthritis & rheumatology.

[20]  J. Hsu,et al.  CD83 is a new potential biomarker and therapeutic target for Hodgkin lymphoma , 2018, Haematologica.

[21]  A. Krawczyk,et al.  Role of L-Particles during Herpes Simplex Virus Infection , 2017, Front. Microbiol..

[22]  Peng Li,et al.  NK cells are negatively regulated by sCD83 in experimental autoimmune uveitis , 2017, Scientific Reports.

[23]  D. Fuchs,et al.  Changes in T Cell and Dendritic Cell Phenotype from Mid to Late Pregnancy Are Indicative of a Shift from Immune Tolerance to Immune Activation , 2017, Front. Immunol..

[24]  P. Höllsberg,et al.  Expression of soluble CD83 in plasma from early‐stage rheumatoid arthritis patients is not modified by anti‐TNF‐&agr; therapy , 2017, Cytokine.

[25]  G. Schett,et al.  Pathogenetic insights from the treatment of rheumatoid arthritis , 2017, The Lancet.

[26]  M. Zygmunt,et al.  A Kinetic Study of CD83 Reveals an Upregulation and Higher Production of sCD83 in Lymphocytes from Pregnant Mice , 2017, Front. Immunol..

[27]  Y. Muller,et al.  Crystal Structure of the Extracellular Domain of the Human Dendritic Cell Surface Marker CD83. , 2017, Journal of Molecular Biology.

[28]  M. Debenedette,et al.  Soluble CD83 Inhibits T Cell Activation by Binding to the TLR4/MD-2 Complex on CD14+ Monocytes , 2017, The Journal of Immunology.

[29]  A. Steinkasserer,et al.  The Major Immediate-Early Protein IE2 of Human Cytomegalovirus Is Sufficient to Induce Proteasomal Degradation of CD83 on Mature Dendritic Cells , 2017, Front. Microbiol..

[30]  J. Hsu,et al.  The Analysis of CD83 Expression on Human Immune Cells Identifies a Unique CD83+-Activated T Cell Population , 2016, The Journal of Immunology.

[31]  H. Ploegh,et al.  Thymic CD4 T cell selection requires attenuation of March8-mediated MHCII turnover in cortical epithelial cells through CD83 , 2016, The Journal of experimental medicine.

[32]  A. Rudensky,et al.  An essential role for IL-2 receptor in regulatory T cell function , 2016, Nature Immunology.

[33]  T. Winkler,et al.  CD83 Modulates B Cell Activation and Germinal Center Responses , 2016, The Journal of Immunology.

[34]  C. Daniel,et al.  L Particles Transmit Viral Proteins from Herpes Simplex Virus 1-Infected Mature Dendritic Cells to Uninfected Bystander Cells, Inducing CD83 Downmodulation , 2015, Journal of Virology.

[35]  Yuetsu Tanaka,et al.  Human T-cell leukemia virus type-I Tax induces the expression of CD83 on T cells , 2015, Retrovirology.

[36]  Qiang Zhou,et al.  Continuous expression of CD83 on activated human CD4+ T cells is correlated with their differentiation into induced regulatory T cells , 2015, Molecular medicine reports.

[37]  M. Raftery,et al.  Dendritic cells as Achilles’ heel and Trojan horse during varicella zoster virus infection , 2015, Front. Microbiol..

[38]  A. Steinkasserer,et al.  CD83 and GRASP55 interact in human dendritic cells. , 2015, Biochemical and biophysical research communications.

[39]  A. Steinkasserer,et al.  Murine CD83-positive T cells mediate suppressor functions in vitro and in vivo. , 2015, Immunobiology.

[40]  T. Malek,et al.  IL-2Rβ–Dependent Signaling and CD103 Functionally Cooperate To Maintain Tolerance in the Gut Mucosa , 2015, The Journal of Immunology.

[41]  María Martín,et al.  UniProt: A hub for protein information , 2015 .

[42]  The Uniprot Consortium,et al.  UniProt: a hub for protein information , 2014, Nucleic Acids Res..

[43]  S. Ho,et al.  Dendritic cell CD83 homotypic interactions regulate inflammation and promote mucosal homeostasis , 2014, Mucosal Immunology.

[44]  A. Steinkasserer,et al.  Herpes simplex virus type 1 ICP0 induces CD83 degradation in mature dendritic cells independent of its E3 ubiquitin ligase function. , 2014, The Journal of general virology.

[45]  A. Zenclussen,et al.  B Cells: The Old New Players in Reproductive Immunology , 2014, Front. Immunol..

[46]  J. Barbuto,et al.  Dendritic cell membrane CD83 enhances immune responses by boosting intracellular calcium release in T lymphocytes , 2014, Journal of leukocyte biology.

[47]  Yugang Guo,et al.  The Expression and Characterization of Functionally Active Soluble CD83 by Pichia pastoris Using High-Density Fermentation , 2014, PloS one.

[48]  A. Pommer,et al.  Soluble CD83 ameliorates experimental colitis in mice , 2014, Mucosal Immunology.

[49]  A. Steinkasserer,et al.  Soluble human CD83 ameliorates lupus in NZB/W F1 mice. , 2013, Immunobiology.

[50]  L. Boon,et al.  Topical Application of Soluble CD83 Induces IDO-Mediated Immune Modulation, Increases Foxp3+ T Cells, and Prolongs Allogeneic Corneal Graft Survival , 2013, The Journal of Immunology.

[51]  T. Winkler,et al.  Multiple Interferon Regulatory Factor and NF-κB Sites Cooperate in Mediating Cell-Type- and Maturation-Specific Activation of the Human CD83 Promoter in Dendritic Cells , 2013, Molecular and Cellular Biology.

[52]  T. Malek,et al.  IL-2R Signaling Is Essential for Functional Maturation of Regulatory T Cells during Thymic Development , 2013, The Journal of Immunology.

[53]  J. Hauber,et al.  Post-transcriptional regulation of CD83 expression by AUF1 proteins , 2012, Nucleic acids research.

[54]  M. Stefanidou,et al.  Herpes Simplex Virus 2 (HSV-2) Prevents Dendritic Cell Maturation, Induces Apoptosis, and Triggers Release of Proinflammatory Cytokines: Potential Links to HSV-HIV Synergy , 2012, Journal of Virology.

[55]  Ling Wang,et al.  Latent Kaposi's Sarcoma-Associated Herpesvirus Infection of Monocytes Downregulates Expression of Adaptive Immune Response Costimulatory Receptors and Proinflammatory Cytokines , 2012, Journal of Virology.

[56]  Xue-guang Zhang,et al.  CD83-stimulated monocytes suppress T-cell immune responses through production of prostaglandin E2 , 2011, Proceedings of the National Academy of Sciences.

[57]  B. Fleischer,et al.  Activated T cells induce rapid CD83 expression on B cells by engagement of CD40. , 2011, Immunology letters.

[58]  C. Goodnow,et al.  CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10–driven MARCH1-mediated ubiquitination and degradation , 2011, The Journal of experimental medicine.

[59]  Hao Wang,et al.  Prevention of Chronic Renal Allograft Rejection by Soluble CD83 , 2010, Transplantation.

[60]  M. Debenedette,et al.  Induction of Kidney Allograft Tolerance by Soluble CD83 Associated With Prevalence of Tolerogenic Dendritic Cells and Indoleamine 2,3-Dioxygenase , 2010, Transplantation.

[61]  A. Steinkasserer,et al.  Immunosuppression Involving Soluble CD83 Induces Tolerogenic Dendritic Cells That Prevent Cardiac Allograft Rejection , 2010, Transplantation.

[62]  S. Ishido,et al.  MARCH-I: A new regulator of dendritic cell function , 2010, Molecules and cells.

[63]  O. Ohara,et al.  Cutting Edge: Requirement of MARCH-I-Mediated MHC II Ubiquitination for the Maintenance of Conventional Dendritic Cells1 , 2009, The Journal of Immunology.

[64]  Q. Pittman,et al.  Early Life Exposure to Lipopolysaccharide Suppresses Experimental Autoimmune Encephalomyelitis by Promoting Tolerogenic Dendritic Cells and Regulatory T Cells1 , 2009, The Journal of Immunology.

[65]  Liwu Li,et al.  Differential Regulation of Foxp3 and IL-17 Expression in CD4 T Helper Cells by IRAK-11 , 2009, The Journal of Immunology.

[66]  B. Fleischer,et al.  Engagement of CD83 on B Cells Modulates B Cell Function In Vivo1 , 2009, The Journal of Immunology.

[67]  J. Hauber,et al.  Phosphorylation of the HuR ligand APRIL by casein kinase 2 regulates CD83 expression , 2009, European journal of immunology.

[68]  B. Fleischer,et al.  CD83 on murine APC does not function as a costimulatory receptor for T cells. , 2008, Immunology letters.

[69]  T. Mak,et al.  The CD83 reporter mouse elucidates the activity of the CD83 promoter in B, T, and dendritic cell populations in vivo , 2008, Proceedings of the National Academy of Sciences.

[70]  W. Stoorvogel,et al.  Endosomal sorting of MHC class II determines antigen presentation by dendritic cells. , 2008, Current opinion in cell biology.

[71]  Lingyun Sun,et al.  Systemic lupus erythematosus patients have increased number of circulating plasmacytoid dendritic cells, but decreased myeloid dendritic cells with deficient CD83 expression , 2008, Lupus.

[72]  M. Probst-Kepper,et al.  CD83 Expression in CD4+ T Cells Modulates Inflammation and Autoimmunity1 , 2008, The Journal of Immunology.

[73]  Nadia Catalan,et al.  MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I down-regulation , 2008, Proceedings of the National Academy of Sciences.

[74]  John P. Moore,et al.  HIV-1 gp120 Mannoses Induce Immunosuppressive Responses from Dendritic Cells , 2007, PLoS pathogens.

[75]  D. Maskell,et al.  Unique Features and Distribution of the Chicken CD83+ Cell1 , 2007, The Journal of Immunology.

[76]  M. Fujimoto,et al.  CD83 Expression Is a Sensitive Marker of Activation Required for B Cell and CD4+ T Cell Longevity In Vivo1 , 2007, The Journal of Immunology.

[77]  R. Watanabe,et al.  CD83 influences cell-surface MHC class II expression on B cells and other antigen-presenting cells. , 2007, International immunology.

[78]  A. Steinkasserer,et al.  Soluble CD14 and CD83 from Human Neonatal Antigen-Presenting Cells Are Inducible by Commensal Bacteria and Suppress Allergen-Induced Human Neonatal Th2 Differentiation , 2007, Infection and Immunity.

[79]  A. Steinkasserer,et al.  CD83 Knockdown in Monocyte-Derived Dendritic Cells by Small Interfering RNA Leads to a Diminished T Cell Stimulation1 , 2007, The Journal of Immunology.

[80]  C. Boutell,et al.  Herpes Simplex Virus Type 1 Induces CD83 Degradation in Mature Dendritic Cells with Immediate-Early Kinetics via the Cellular Proteasome , 2007, Journal of Virology.

[81]  A. Steinkasserer,et al.  CD83: an update on functions and prospects of the maturation marker of dendritic cells , 2007, Archives of Dermatological Research.

[82]  S. Fillatreau,et al.  CD83 is a regulator of murine B cell function in vivo , 2007, European journal of immunology.

[83]  P. Xiong,et al.  A limited course of soluble CD83 delays acute cellular rejection of MHC‐mismatched mouse skin allografts , 2007, Transplant international : official journal of the European Society for Organ Transplantation.

[84]  J. Aerts,et al.  CD83 expression on dendritic cells and T cells: Correlation with effective immune responses , 2007, European journal of immunology.

[85]  F. Belardelli,et al.  The biology of dendritic cells and HIV infection , 2007 .

[86]  D. Neuberg,et al.  Engagement of CD83 ligand induces prolonged expansion of CD8+ T cells and preferential enrichment for antigen specificity. , 2006, Blood.

[87]  A. Steinkasserer,et al.  Levels of the soluble forms of CD80, CD86, and CD83 are elevated in the synovial fluid of rheumatoid arthritis patients. , 2006, Tissue antigens.

[88]  C. Rinaldo,et al.  Human Immunodeficiency Virus Type 1 Vpr Impairs Dendritic Cell Maturation and T-Cell Activation: Implications for Viral Immune Escape , 2005, Journal of Virology.

[89]  Heinrich Sticht,et al.  CD83 is a dimer: Comparative analysis of monomeric and dimeric isoforms. , 2005, Biochemical and biophysical research communications.

[90]  T. Bieber,et al.  CD83 localization in a recycling compartment of immature human monocyte-derived dendritic cells. , 2005, International immunology.

[91]  D. Weiner,et al.  HIV-1 Vpr inhibits the maturation and activation of macrophages and dendritic cells in vitro. , 2004, International immunology.

[92]  W. Cao,et al.  CD83 is preformed inside monocytes, macrophages and dendritic cells, but it is only stably expressed on activated dendritic cells. , 2005, The Biochemical journal.

[93]  F. Belardelli,et al.  Human Immunodeficiency Virus Type 1 gp120 Induces Abnormal Maturation and Functional Alterations of Dendritic Cells: a Novel Mechanism for AIDS Pathogenesis , 2004, Journal of Virology.

[94]  S. Proll,et al.  A Novel Mutation in CD83 Results in the Development of a Unique Population of CD4+ T Cells , 2004, The Journal of Immunology.

[95]  A. Steinkasserer,et al.  Prevention and Treatment of Experimental Autoimmune Encephalomyelitis by Soluble CD83 , 2004, The Journal of experimental medicine.

[96]  James W. Young,et al.  Infection of mature monocyte-derived dendritic cells with human cytomegalovirus inhibits stimulation of T-cell proliferation via the release of soluble CD83. , 2004, Blood.

[97]  Christine Trumpfheller,et al.  HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[98]  P. Stone,et al.  CD83(+)dendritic cells in the decidua of women with recurrent miscarriage and normal pregnancy. , 2004, Placenta.

[99]  B. Fleischer,et al.  Enhanced Activation of CD83‐Positive T Cells * , 2003, Scandinavian journal of immunology.

[100]  Wolfgang Hammerschmidt,et al.  Latent Membrane Protein 1 of Epstein-Barr Virus Induces CD83 by the NF-κB Signaling Pathway , 2003, Journal of Virology.

[101]  A. Cunningham,et al.  Varicella-Zoster Virus Productively Infects Mature Dendritic Cells and Alters Their Immune Function , 2003, Journal of Virology.

[102]  K. Andrassy,et al.  Up‐regulation of the dendritic cell marker CD83 on polymorphonuclear neutrophils (PMN): divergent expression in acute bacterial infections and chronic inflammatory disease , 2002, Clinical and experimental immunology.

[103]  A. Mehl,et al.  Human cytomegalovirus inhibits maturation and impairs function of monocyte-derived dendritic cells. , 2002, Blood.

[104]  M. Fujimoto,et al.  CD83 Expression Influences CD4+ T Cell Development in the Thymus , 2002, Cell.

[105]  G. Schuler,et al.  Cloning and characterization of the promoter region of the human CD83 gene. , 2002, Immunobiology.

[106]  E. Kremmer,et al.  The Extracellular Domain of CD83 Inhibits Dendritic Cell–mediated T Cell Stimulation and Binds to a Ligand on Dendritic Cells , 2001, The Journal of experimental medicine.

[107]  M. Grisham,et al.  Immunological Basis of Inflammatory Bowel Disease: Role of the Microcirculation , 2001, Microcirculation.

[108]  B. Hock,et al.  A soluble form of CD83 is released from activated dendritic cells and B lymphocytes, and is detectable in normal human sera. , 2001, International immunology.

[109]  J. Ledbetter,et al.  CD83 Is a Sialic Acid-Binding Ig-Like Lectin (Siglec) Adhesion Receptor that Binds Monocytes and a Subset of Activated CD8+ T Cells1 , 2001, The Journal of Immunology.

[110]  J. Ledbetter,et al.  CD83 is an I-type lectin adhesion receptor that binds monocytes and a subset of activated CD8+ T cells [corrected]. , 2001, Journal of immunology.

[111]  B. Fleischer,et al.  Activation-induced expression of murine CD83 on T cells and identification of a specific CD83 ligand on murine B cells. , 2000, International immunology.

[112]  D. Nixon,et al.  Requirement of Mature Dendritic Cells for Efficient Activation of Influenza A-Specific Memory CD8+ T Cells1 , 2000, The Journal of Immunology.

[113]  J. Hauber,et al.  Inhibition of Cd83 Cell Surface Expression during Dendritic Cell Maturation by Interference with Nuclear Export of Cd83 mRNA , 2000, The Journal of experimental medicine.

[114]  R. Steinman,et al.  Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion. , 1999, Journal of immunology.

[115]  G. Schuler,et al.  Cloning, recombinant expression and biochemical characterization of the murine CD83 molecule which is specifically upregulated during dendritic cell maturation , 1999, FEBS letters.

[116]  A. Lanzavecchia,et al.  Inhibition of dendritic cell maturation by herpes simplex virus , 1999, European journal of immunology.

[117]  D. Sheer,et al.  The human dendritic cell marker CD83 maps to chromosome 6p23 , 1999, Annals of human genetics.

[118]  C. Disteche,et al.  The mouse Cd83 gene: structure, domain organization, and chromosome localization , 1998, Immunogenetics.

[119]  O. Majdic,et al.  Neutrophil Granulocyte–committed Cells Can Be Driven to Acquire Dendritic Cell Characteristics , 1998, The Journal of experimental medicine.

[120]  Liangji Zhou,et al.  CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[121]  Liangji Zhou,et al.  A distinct pattern of cytokine gene expression by human CD83+ blood dendritic cells. , 1995, Blood.

[122]  Liangji Zhou,et al.  Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. , 1995, Journal of immunology.

[123]  T. Tedder,et al.  New CD from the B cell section of the Fifth International Workshop on Human Leukocyte Differentiation Antigens. , 1994, Leukemia & lymphoma.

[124]  C. Fox,et al.  Subtractive cDNA cloning of a novel member of the Ig gene superfamily expressed at high levels in activated B lymphocytes , 1993 .

[125]  Liangji Zhou,et al.  A novel cell-surface molecule expressed by human interdigitating reticulum cells, Langerhans cells, and activated lymphocytes is a new member of the Ig superfamily. , 1992, Journal of immunology.

[126]  E. B. Wilson,et al.  PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES. , 1916, Science.